Gyne Robot Surg Search


Publication ethics

  • HOME
  • Publication ethics

1. Research Ethics

All of the manuscripts should be prepared based on strict observation of research and publication ethics guidelines recommended by the Council of Science Editors (, International Committee of Medical Journal Editors (ICMJE,, and World Association of Medical Editors (WAME, All studies involving human subjects or human data must be reviewed and approved by a responsible Institutional Review Board (IRB). Please refer to the principles embodied in the Declaration of Helsinki ( for all investigations involving human materials. Animal experiments also should be reviewed by an appropriate committee (IACUC) for the care and use of animals. Also studies with pathogens requiring a high degree of biosafety should pass review of a relevant committee (IBC). The approval should be described in the Methods section. For studies of humans including case reports, state whether informed consents were obtained from the study participants. The editor of GRS may request submission of copies of informed consents from human subjects in clinical studies or IRB approval documents. The GRS will follow the guidelines by the Committee on Publication Ethics (COPE, for settlement of any misconduct.

2. Conflict of Interest

The corresponding author of an article is asked to inform the Editor of the authors' potential conflicts of interest possibly influencing the research or interpretation of data. A potential conflict of interest should be disclosed in the cover letter even when the authors are confident that their judgments have not been influenced in preparing the manuscript. Such conflicts may include financial support or private connections to pharmaceutical companies, political pressure from interest groups, or academic problems. Disclosure form shall be same with ICMJE Uniform Disclosure Form for Potential Conflicts of Interest ( The Editor will decide whether the information on the conflict should be included in the published paper. In particular, all sources of funding for a study should be explicitly stated. The GRSasks referees to let its Editor know of any conflict of interest before reviewing a particular manuscript.

Statement of Informed Consent
Copies of written informed consent and institutional review board (IRB) approval for clinical research should be retained for reference as necessary. Please insert a sentence in the Materials and Methods section stating that the study was approved or exempt from approval and include the name of the IRB.

Statement of Human and Animal Rights
All human investigations must be conducted according to the principles expressed in the Declaration of Helsinki. All studies involving animals must state that guidelines of the authors’ institution, or any applicable national law, regarding the use and care of laboratory animals were followed.

Selection and Description of Participants
Clearly describe the selection of observational or experimental participants (healthy individuals or patients, including controls), including eligibility and exclusion criteria and a description of the source population. Because the relevance of such variables as age, sex, or ethnicity is not always known at the time of study design, researchers should aim for inclusion of representative populations into all study types and at a minimum provide descriptive data for these and other relevant demographic variables. Ensure correct use of the terms sex (when reporting biological factors) and gender (identity, psychosocial or cultural factors), and, unless inappropriate, report the sex and/or gender of study participants, the sex of animals or cells, and describe the methods used to determine sex and gender. If the study was done involving an exclusive population, for example in only one sex, authors should justify why, except in obvious cases, (e.g., prostate cancer).” Authors should define how they determined race or ethnicity and justify their relevance.

Originality and Duplicate Publication
All submitted manuscripts should be original; further, they should not be under consideration for publication by other scientific journals. Any part of the accepted manuscript may not be duplicated in any other scientific journal without the permission of the editorial board. If duplicate publication related to a paper in this journal is detected, the author(s) will be named in the journal, and the respective institute(s) of affiliation will be informed; additionally, there will be penalties for the author(s).

Registration of Clinical Trial Research
It is recommended that research dealing with a clinical trial be registered with a primary national clinical trial registration site such as, or other sites accredited by the World Health Organization (WHO) or the International Committee of Medical Journal Editors.

Copyright and Licensing


Browse all articles >

Editorial Office
Department of Obstetrics and Gynecology, The Catholic University of Korea Seoul St. Mary's Hospital 9F, 222 Banpo-daero, Seocho-Gu, Seoul 06591, Korea
Tel: +82-53-258-4847    Fax: +82-53-258-4848    E-mail:                

Copyright © 2024 by Society of Korean Robotic Gynecologic Surgery.

Developed in M2PI

Close layer
prev next